Thymocyte maturation is regulated primarily by signaltransducing receptors that are distinct from those that control chemotaxis; these include the T cell receptor (TCR) and its precursor, the pre-TCR, each of which controls important checkpoints in T cell development. Interestingly, the signals that drive the differentiation of thymocytes also influence their migration through successive thymic environments and their eventual exit from the thymus 2, 3 . In this Review, we summarize what is currently known about the migration of conventional CD4 + and CD8 + thymocytes and their precursors in the adult thymus. Special attention is given to how crosstalk between developmental and chemotactic receptors contributes to T cell maturation and how developmental signals ensure that continued migration and export are linked to and dependent on proper thymocyte maturation. Discussion of thymic organogenesis and fetal thymic colonization is not included here, but these topics are covered in several excellent recent reviews 2, [4] [5] [6] .
T cell progenitors in the bone marrow
The identity of the haematopoietic progenitor cells that colonize the thymus from the blood has not been definitively established. Very low numbers of bone marrow-derived progenitor cells are thought to circulate and populate the thymus and, for this reason, studies of direct thymic colonization by progenitor cells are technically very demanding. Initial efforts to identify T cell progenitors attempted to describe them as haematopoietic cells expressing specific combinations of cytokine receptors and possessing limited lineage potentials 7, 8 . However, bone marrow-derived pro genitors at many stages of differentiation give rise to T cells if they are directly exposed to the thymic environment 1 . The difference between physiological progenitors of T cells and other progenitors with T cell potential appears to be the ability to migrate to the thymus. Consequently, a definition of physiological T cell progenitors requires a description of the expressed thymus-homing molecules.
The earliest haematopoietic progenitors in the bone marrow do not express the lineage markers found on differentiated cells, but express the stem cell markers stem cell antigen 1 (SCA1; also known as LY6A) and KIT (also known as SCFR); they are therefore known as LSK cells 1 . This LSK cell population is heterogeneous, and it has been further characterized based on expression of the cytokine receptor FMS-related tyrosine kinase 3 (FLT3) and of other markers such as CD150 and CD48 (REF. 9 ). The CD150 + FLT3 -subset of LSK cells contains long-term self-renewing haemato poietic stem cells (HSCs), whereas more mature CD150 G protein-coupled receptors (GPCRs) . A family of receptors that are each composed of seven membrane-spanning helical segments. These receptors associate with heterotrimeric G proteins, which are a family of intracellular signalling proteins that have common β-and γ-chains, and one of several α-chains. The α-chain determines the nature of the signal that is transmitted from a ligand-occupied GPCR to downstream effector systems. hi initiates transcription of recombination activating gene 1 (RAG1) and RAG2, and these cells are termed lymphoid-primed multipotent progenitors (LMPPs; also known as ELPs). Subsequent lymphoid-primed bone marrow progenitors include common lymphoid progenitors (CLPs). All of these progenitors will make T cells if placed within the thymus. However, the ability of haematopoietic progenitors to migrate to the thymus is regulated, and requires, among other molecules, CC-chemokine receptor 9 (CCR9; which is expressed by subsets of LMPPs and CLPs) and CCR7 (which is expressed by some LMPPs and highly expressed by CLPs). The identity of in vivo thymus-settling progenitors (TSPs) has not been precisely determined, but they probably include LMPPs and CLPs. TSPs enter the thymus near the cortico-medullary junction to generate early T cell progenitors (ETPs; also known as KIT + double negative 1 (DN1) thymocytes). ETPs in turn generate DN2 and DN3 cells that migrate to the subcapsular zone. Expression of the pre-T cell receptor (pre-TCR) and CXC-chemokine receptor 4 (CXCR4) on DN3 thymocytes induces cell proliferation and differentiation to the DN4 and subsequently to the double positive (DP) stage. DP thymocytes express high levels of CCR9 (not shown); however, the function of CCR9 in DP thymocytes remains unclear. DP thymocytes that form appropriate interactions with self peptide-MHC complexes on cortical thymic epithelial cells (a process termed positive selection) upregulate expression of CCR7 and mature into single positive (SP) mature T cells that migrate into the thymic medulla. Residence in the medulla (where negative selection occurs) is followed by emigration, which is regulated by sphingosine-1-phosphate receptor 1 (S1P 1 ). PSGL1, P-selectin glycoprotein ligand 1.
pre-TCR
A receptor that is expressed on pre-T cells. It is formed by a T cell receptor (TCR) β-chain paired with a surrogate TCR α-chain (known as the invariant pre-Tα protein). The receptor complex includes CD3 proteins and transduces signals that allow further T cell development.
LSK cells
A mouse cell population that is defined by the expression of stem cell antigen 1 (SCA1) and the receptor for stem cell factor, KIT, and the absence of lineage or maturation markers (LIN -). This is a heterogeneous population that contains multipotent progenitors and true self-renewing stem cells and is highly enriched in HSCs.
retain the ability to differentiate into all blood cell types, and are therefore designated multipotent progenitors (MPPs) [9] [10] [11] [12] . LSK cells with the highest levels of FLT3 expression also express lymphoid-specific genes and are termed lymphoid-primed MPPs (LMPPs) or early lymphoid progenitors (ELPs) 11, 13, 14 . Common lymphoid progenitors (CLPs), which are not part of the LSK cell pool, were initially defined as devoid of nonlymphoid lineage potentials 7 . More recently, the LY6D -subset of CLPs was shown to retain some myeloid and natural killer cell potential in in vitro assays 15, 16 . HSCs, MPPs, LMPPs and CLPs will each produce progeny of the T cell lineage if directly placed in the thymic environment 17, 18 (FIG. 1) .
In addition to these populations, CD3
-CD4 -CD8 -CD25 + CD44 -pre-T cells that are similar to double negative 3 (DN3) thymocytes exist in low numbers in the bone marrow, blood and spleen of normal mice [19] [20] [21] [22] [23] [24] and expand greatly in the spleen following bone marrow transplantation [25] [26] [27] . However, their role, if any, in normal T cell development requires clarification.
Getting to the thymus Although T cell potential is broadly distributed across various haematopoietic cell subsets, the ability to home to the thymus is regulated and thymic homing is selective 18, 28 . Early work established that stem cell activity is not evident within the thymus, suggesting that HSCs are unlikely to efficiently home to and enter the thymus 29 . More recently, it was shown that whereas HSCs, MPPs, LMPPs and CLPs each possess T cell potential and generate thymocytes when injected intrathymically, only LMPPs and CLPs rapidly generate thymocytes after intravenous transfer 18 (FIG. 1) . These results show that HSCs and most MPPs are not capable of colonizing the thymus from the blood and that this ability must instead be attained during later stages of differentiation.
The mechanisms by which progenitors home to the thymus have been suggested to be similar to those by which leukocytes enter lymph nodes and tissues 30, 31 . As leukocytes pass through postcapillary venules, they use selectins, chemokine receptors and integrins in a regulated signalling cascade to arrest at the endothelial wall and extravasate 31 . It is likely that progenitor egress from the blood into the thymus mirrors the steps used by other cells in lymph node and tissue homing. Several molecules expressed on progenitor cells have been suggested to have a role in thymic homing. The strongest experimental data exist for CC-chemokine receptor 7 (CCR7) 28, 32 , CCR9 (REFS 18, (33) (34) (35) (36) and P-selectin glycoprotein ligand 1 (PSGL1) 37, 38 (see below). However, contributions from other molecules, including CXCchemokine receptor 4 (CXCR4) 39 , CCR5 (REF. 40 ) and ephrin type B receptor 2 (EPHB2) 41 , to the regulation of thymic homing have also been suggested.
CCR7 and CCR9.
The ligands for CCR7 (namely, CC-chemokine ligand 19 (CCL19) and CCL21) and for CCR9 (namely, CCL25) are expressed in the thymus. CCL25 is broadly expressed by thymic stromal cells, whereas CCR7 ligands are most densely expressed in the medulla, and both sets of ligands are expressed by the thymic endothelium [34] [35] [36] [37] [42] [43] [44] [45] . In the absence of CCR7 or CCR9, thymic migration and T cell development are delayed in fetal mice 34, 42 . In adult mice lacking CCR7 and/or CCR9, the thymus is of near-normal size; however, thymic colonization by Ccr7 -/-Ccr9 -/-progenitors is almost completely blocked under competitive conditions 28, 46 . LMPPs and CLPs express functional CCR7 and CCR9, whereas HSCs and MPPs do not 18, 28, 47 . Consistently, efficient thymic-colonizing capacity resides within the LIN -KIT +
FLT3
hi pool of bone marrow pro genitors, which includes both LMPPs and CLPs but excludes HSCs and MPPs 18, 46, 48 . CCR9-expressing LMPPs retain the ability to make lymphoid and myeloid cell lineages (although they do not give rise to erythroid lineages), implying that the thymus must be able to prevent incoming progenitors from manifesting myeloid and other (non-T cell) lymphoid fates 47, [49] [50] [51] [52] .
CCR9
+ and CCR9 -progenitors exhibit similar differentiation potentials and gene expression profiles in the fetal thymus, suggesting that otherwise similar progenitors may access the fetal thymus via distinct homing pathways 53 . In addition to LMPPs and CLPs, other subsets of T cell progenitors express CCR7 and/ or CCR9, and might also contribute to T cell development (TABLE 1 ). The relative contributions of different progenitor populations to T cell development are not known with certainty.
PSGL1. PSGL1, a glycoprotein expressed on T cell progenitors, serves as a ligand for P-selectin, which is found on the thymic endothelium 37, 38 . Expression of functional PSGL1 requires glycosylation, and the functional molecule is broadly expressed on bone marrow progenitors, whereas expression of P-selectin on thymic endothelial cells has been suggested to be dynamically regulated 37, 38 . The expression of P-selectin appears to be periodically upregulated on thymic endothelial cells, together with CCL25 expression, and this may provide a molecular explanation for the observation that the mouse thymus is only periodically receptive to intravenously administered progenitors 37, 54 .
Migration within the thymus
After entering the thymus, immature progenitors undergo further differentiation and eventually become irreversibly committed to the T cell lineage. The first steps in the T cell developmental process can be defined by four stages of maturation that precede expression of high levels of CD4 and/or CD8; these cells are referred to as double negative cells (DN cells) (TABLE 1) . T cell lineage commitment occurs at the DN3 stage coincidently with the initiation of V(D)J rearrangement of the TCR β-chain (Tcrb), TCR γ-chain (Tcrg) and TCR δ-chain (Tcrd) genes. Productive rearrangement of Tcrg and Tcrd induces commitment to the γδ T cell lineage. By contrast, productive rearrangement of Tcrb leads to the expression of the pre-TCR, which together with Notch-mediated signalling induces cell proliferation and the differentiation of DN3 thymocytes to the DN4 stage (an event referred to as β-selection) 55 and subsequently to the double positive (DP; CD4
Migration to the subcapsular zone. In adult mice, thymus-settling progenitors (TSPs) enter the thymus close to the cortico-medullary junction, which is highly vascularized. These rare TSPs may undergo extensive proliferation during a prolonged residence near the cortico-medullary junction 56 to generate early T cell progenitors (ETPs; also known as early thymic progenitors or KIT + DN1 cells) before their progeny migrate outwards to the subcapsular zone.
As ETPs move into the cortex they differentiate into DN2 and then DN3 thymocytes (FIG. 1) . Roles for CXCR4, CCR7 and CCR9 in regulating the initial migration of early progenitors from the cortico-medullary junction to the cortex have been suggested 45, 57, 58 ; however, none of these GPCRs appear to be essential for this transition. Moreover, the ligands for CCR7 (which are predominantly expressed and localized in the medulla) do not appear to be positioned to induce movement of cells away from the cortico-medullary junction 43, 45 . It is worth noting that estimates of cortical transit times (~13-15 days) indicate that the migration of DN thymocytes from the corticomedullary junction to the subcapsular zone is unusually slow 59 , and the movement of cortical DN thymocytes appears to lack obvious directional bias. This could indicate that, rather than migrating via active chemotaxis, cortical migration of DN thymocytes is directed mainly by integrin-mediated cell-cell and cell-matrix interactions that are perhaps facilitated by chemokine signalling in the absence of defined chemokine gradients 60 . After reaching the subcapsular zone, DN3 cells undergo extensive proliferation and then transition to the DN4 stage, a process that depends on the expression of and signalling by the pre-TCR. Pre-TCR signalling upregulates CCR9 on DN3 thymocytes 61 , and CCR9 has been shown to be important for the proper localization of DN3 thymocytes to the subcapsular zone 57 . However, in the absence of CCR9, subsequent steps of thymocyte development do not appear to be affected, suggesting that CCR9-mediated migration of DN thymocytes to the subcapsular zone is not essential for maturation to the DP stage 57 . Conditional deletion of CXCR4 results in the accumulation of DN2 and/or DN3 cells in the outer cortex but, unlike deletion of CCR9, differentiation from the DN3 to the DN4 stage is impaired in the absence of CXCR4 (REF. 62 ). This developmental defect appears to be due to the loss of CXCR4-mediated survival and proliferation signals rather than the mislocalization of DN thymocytes, indicating that CXCR4 functions as a costimulator along with the pre-TCR during β-selection 62 .
Interestingly, the same study demonstrated that CXCR4-mediated chemotaxis is potentiated by pre-TCR signalling, indicating that there is reciprocal crosstalk between the pre-TCR and CXCR4 in DN3 thymocytes and that this is crucial for β-selection 62 .
Migration from the cortex to the medulla. After reaching the subcapsular zone, thymocytes reverse direction and migrate once again back into the cortex (FIG. 1) . Coincidently with their movement into the cortex, DN4 thymocytes begin to express CD4 and CD8 on their cell surface and transition to the DP stage. Newly formed DP cells express both CXCR4 and CCR9 and can migrate towards CXC-chemokine ligand 12 (CXCL12) and CCL25. However, a requirement for CXCR4-or CCR9-mediated signals for the movement of cells out of the subcapsular zone has not been firmly established 33, 45, 58, 61, 63 . One hypothesis to explain the 'retrograde' migration of DP thymocytes out of the subcapsular zone is that rather than being actively directed by chemokine-mediated signals, the proliferative burst that occurs at the DN3 stage results in the passive cortical translocation and inward movement of daughter DN4 and DP cells 60 . Indeed, results obtained using two-photon laser scanning microscopy with intact thymus lobe cultures in mice 64 and by intravital imaging in fish 65 indicate that most immature DP thymocytes move randomly at low motility rates. It has also been proposed that the inward movement of DP thymocytes may be facilitated by interstitial fluid currents that flow directionally from the subcapsular zone to the medulla 4 . However, as passive or non-directional mechanisms cannot explain both the outward and inward cortical migration of thymocytes, it is clear that additional, as yet undefined, factors must be involved in regulating the bidirectional cortical movement of thymocytes at different stages of development.
In the cortex, productive rearrangement of Tcra in DP thymocytes results in the replacement of the pre-TCR with the clonotypic αβ TCR complex. DP cells that express TCRs capable of generating low-intensity activating signals following interaction with self ligands undergo positive selection in the cortex. These cells transition into either CD4 + CD8
-(CD4 single positive (SP)) 36, 68 and directed migration towards the medulla 64 , whereas immature DP thymocytes appear to be unable to migrate on medullary stroma 69 . This suggests that chemotaxis to the medulla is initiated (or augmented) in DP thymocytes by positive selection signals transduced by the TCR in the cortex.
Several studies have concluded that the entry of immature SP thymocytes into the medulla is dependent on CCR7 (REFS 44, 70, 71) . Supporting this interpretation, overexpression of CCR7 results in the mislocalization of DP thymocytes to the medulla 70 and, in the absence of CCR7, the negative selection of thymocytes that express TCRs reactive to tissue-restricted antigens is markedly compromised 71, 72 . However, a recent study suggested that CCR7 is not required for the migration of SP thymocytes on medullary substrates, although it confirmed a role for CCR7 in directing the migration of cortical CD4 SP thymocytes towards the medulla 69 . In addition, the same study concluded that CCR7 is not required for the entry of CD4 SP thymocytes into the medulla 69 . However, as these experiments were performed in vitro by seeding SP thymocytes onto thymus slices, it is unclear whether they accurately reflect the in vivo requirements for medullary entry.
Another study found a reduction in medullary CD8 SP but not CD4 SP thymocytes in the absence of CCR7, concluding that CCR7 is not essential for the entry of CD4 SP thymocytes into the medulla 67 . In addition, the authors detected defects in TCR-mediated activation responses in both DP and CD4 SP thymocytes. This suggests that CCR7 augments TCR signalling and that defects in this pathway, rather than failure to enter the medulla, may underlie the reduced efficiency of negative selection in Ccr7 -/-mice 67 . Nevertheless, subsequent findings indicate that medullary entry of CD4 SP thymocytes is still compromised in the absence of CCR7 (REF. 72 ). The apparent differential dependence of CD4 SP and CD8 SP thymocytes on CCR7 may be due to the fact that CCR7 is upregulated on a higher percentage of DP thymocytes undergoing positive selection into the CD8 SP lineage (compared with those entering the CD4 SP lineage) 73 . Taken together, these data suggest that additional factors may be important for medullary entry, particularly of CD4 SP thymocytes. Interestingly, two studies reported that the entry of SP thymocytes into the medulla is blocked completely by the pan-GPCR inhibitor pertussis toxin, indicating that this process is critically dependent on GPCR-mediated signalling 69, 74 .
Export of mature T cells from the thymus. As SP thymocytes migrate within the medulla, they are screened for high-affinity self peptide-TCR interactions capable of triggering negative selection. The expression of tissuespecific self antigens by thymic epithelial cells (TECs) is regulated by autoimmune regulator (AIRE)-dependent transcription 75 , and these self peptides are crosspresented by medullary dendritic cells (DCs). Medullary thymocytes migrate rapidly and make frequent contacts with DCs; however, their movement is markedly slowed if they encounter ligands that induce negative selection 69, 76 . During their estimated 4-5 day sojourn in the thymus, SP thymocytes undergo terminal differentiation, transitioning from a semi-mature activated CD69 hi CD62L low CD24 hi phenotype to a mature quiescent CD69 low CD62L hi CD24 low phenotype. During this transition they may be subjected to negatively selecting stimulation by self antigens and are especially susceptible to pro-apoptotic stimuli. However, following their terminal differentiation, SP thymocytes become functionally competent, are relatively refractory to apoptosis and are poised for export [77] [78] [79] . All medullary SP thymocytes express high levels of CCR7, and restricted subsets also express CCR8, CCR9 and CXCR4 (REFS 33, 36, 45, (80) (81) (82) . Although CCR7 and CXCR4 have been shown to have roles in fetal thymocyte egress 43, 83 , there appears to be no obligatory requirement for any particular chemokine receptor for the export of adult thymocytes 35, 44, 84 . However, some caution is warranted when interpreting these studies in view of data demonstrating that deletion of these chemokine genes at earlier stages can result in developmental defects 62, 67 and because the effects of SP stage-specific gene deletions have not yet been determined.
In contrast to the relatively mild effects of single chemokine receptor gene deletions, deficiency of the GPCR sphingosine-1-phosphate receptor 1 (S1P 1 ; encoded by S1PR1) results in marked accumulation of mature SP thymocytes in the medulla. This is due to the failure of these cells to exit the thymus, identifying S1P 1 as a major regulator of thymocyte egress 85, 86 . S1P 1 is preferentially expressed by mature SP thymocytes 85, 86 , and its ligand, sphingosine-1-phosphate (S1P), is produced by neural crest-derived pericytes in the corticomedullary junction 87 and is highly concentrated in the circulation 88 . Thus, S1P provides a chemotactic gradient for the migration of mature SP thymocytes towards the vascularized cortico-medullary junction and then out of the thymus.
TCR signalling in thymocyte export
The identification of a pivotal role for S1P 1 in controlling thymocyte export provides a clear mechanism for how mature SP thymocytes are directed to sites of thymic egress. However, an unresolved question is how thymocyte export is appropriately timed such that only functionally mature, post-selection SP thymocytes are permitted to exit the thymus. The importance of this issue is underscored by the consequences of allowing SP thymocytes to exit the thymus before completing the process of negative selection, which are exemplified TCR signalling results in the AKT-mediated phosphorylation of the transcription factor forkhead box O1 (FOXO1), leading to the inactivation and nuclear export of FOXO1. Retention of FOXO1 in the cytoplasm leads to the downregulation of Krüppel-like factor 2 (Klf2) expression, which is required for the transcription of CC-chemokine receptor 7 (Ccr7), Sell (which encodes CD62L) and sphingosine-1-phosphate receptor 1 (S1pr1; which encodes S1P 1 ). In addition, TCR signalling induces the expression of CD69, which downregulates the surface expression of S1P 1 . Loss of S1P 1 surface expression prevents premature S1P-mediated thymocyte export from the thymus. b | SP thymocytes that survive (or do not undergo) negative selection become functionally mature, and TCR signalling is terminated. Cessation of TCR signalling terminates AKT-mediated FOXO1 phosphorylation and results in the nuclear translocation of transcriptionally active FOXO1. FOXO1 promotes the transcription of Klf2, and KLF2 induces the expression of Ccr7, Sell and S1pr1. Termination of TCR signalling also results in the eventual downregulation of CD69, alleviating CD69-directed downregulation of S1P 1 surface expression. Increased surface expression of S1P 1 renders SP thymocytes responsive to S1P chemotactic signals and promotes the migration of these cells towards the cortico-medullary junction and their export from the thymus.
14-3-3
A family of conserved proteins present in all eukaryotic organisms that are involved in such diverse cellular processes as apoptosis and stress, as well as intracellular signalling and cell cycle regulation. 14-3-3 proteins function as adaptors in protein interactions and can regulate protein localization and enzymatic activity. Approximately 100 binding partners for the 14-3-3 proteins have been reported.
by the severe autoimmune disease in AIRE-deficient humans and mice 75 . When taken together, the results of several unrelated studies suggest a mechanism in which the timing of thymocyte export is ultimately regulated by TCR signalling (FIG. 2) . Especially relevant are two recent findings: first, that the transcription factor Krüppel-like factor 2 (KLF2) is required for the expression of S1P 1 (REF. 89); and second, that KLF2 is positively regulated by the transcription factor forkhead box O1 (FOXO1) 78, 90 . As expected from these results, thymocyte export is also impaired in Klf2 -/-or Foxo1 -/-mice [91] [92] [93] . The activity of FOXO1 is regulated by its subcellular localization, which in turn is controlled by its posttranslational modification 94 . Notably, phosphorylation of FOXO1 by the serine/threonine protein kinase AKT (also known as PKB) reduces its DNA-binding activity and results in the nuclear export of FOXO1 by promoting its interaction with the 14-3-3 chaperone proteins 94 . TCR engagement is a potent activator of the phosphoinositide 3-kinase (PI3K)-AKT pathway 95 , providing a mechanism by which TCR stimulation can regulate the expression of S1P 1 and therefore control the timing of thymocyte export (FIG. 2) .
Thus, we propose the following model. In semimature CD69 + SP thymocytes that are receiving (or have recently received) activating signals through TCR engagement with self ligands, FOXO1 is phosphorylated by AKT. Downregulation of FOXO1 transcriptional activity leads to reduced transcription of KLF2 and S1PR1, resulting in thymic retention (FIG. 2a) . Notably, this regulatory mechanism serves to prevent the export of SP thymocytes until they have completed their maturation and been screened for self-reactivity by negative selection. Fully mature quiescent SP thymocytes are CD69 -, which indicates that TCR signalling has ceased. This results in the upregulation of FOXO1 activity and increased KLF2 and S1PR1 transcription, thereby priming cells for thymic export (FIG. 2b) . Indirect support for this model
Lmo2-transgenic mice
Transgenic mice that overexpress Lmo2 (also known as rhombotin 2) in immature thymocytes. Adult Lmo2-transgenic mice develop thymocyte tumours (that is, T cell acute lymphoblastic leukaemia (T-ALL)).
is provided by the findings that thymocyte export is blocked by transgenic expression of constitutively active PI3K 96 or inactivation of the inhibitor of PI3K signalling PTEN (phosphatase and tensin homologue) 97 , as well as by antigen-mediated activation of mature thymocytes 98 . Interestingly, FOXO1 has been shown to control the expression of CD62L (encoded by SELL) and CCR7 (REF. 90 ), in addition to that of S1P 1 , perhaps through its regulation of KLF2 (REF. 89 ). Consequently, TCR signalling controls the expression of CCR7 and CD62L as well as S1P 1 . Although CCR7 and CD62L do not appear to be required for thymocyte export, both molecules, together with S1P 1 , are known to have important roles in regulating peripheral transmigration of T cells into secondary lymphoid tissues 97, 99 . The discovery of reciprocal inhibition by CD69 and S1P 1 suggests that TCR signalling also provides a second tier of regulatory control over thymocyte export 100, 101 . CD69 is a transmembrane C-type lectin protein that is rapidly and transiently upregulated following TCR engagement 102 . An initial clue to a potential regulatory interaction between CD69 and S1P 1 was the observation that mature SP thymocytes in S1pr1 -/-mice fail to downregulate CD69 (REF. 86 ) and, conversely, that treatment with the S1P 1 agonist FTY720 results in the down regulation of CD69 on thymocytes 103 . These findings indicate that S1P 1 signalling inhibits CD69 surface expression. Subsequently, it was shown that CD69 associates with S1P 1 and inhibits the function of this receptor by inducing its internalization and degradation 100, 101 . Consistent with these results, constitutive (transgenemediated) expression of CD69 by SP thymocytes inhibits their export from the thymus 104 . Thus, TCR-induced expression of CD69 on activated semi-mature SP thymocytes downregulates surface expression of S1P 1 , thereby preventing premature thymocyte egress (FIG. 2) . As TCR signalling is terminated and CD69 is downregulated, mature SP thymocytes become responsive to S1P and are capable of exiting the thymus. For the majority of SP thymocytes (those that do not express highly selfreactive TCRs and are therefore not subjected to negative selection), CD69 downregulation and the acquisition of S1P responsiveness may simply reflect the gradual termination of signals induced by positively selecting interactions. However, for SP thymocytes that are subjected to and survive negative selection, CD69 down regulation could result from active 'tuning' of TCR signalling through the regulated expression of inhibitory molecules, such as CD5 . Collectively, these findings provide strong evidence that TCR signalling has an important role in controlling the timing of thymocyte emigration by regulating the surface expression of S1P 1 .
Outstanding questions and conclusions
The reason why thymic homing is so tightly restricted to specific progenitor populations remains unclear. One possibility is that selective thymic settling serves to exclude inappropriate progenitors, such as those retaining efficient myeloid and erythroid lineage potential, from the thymus. This may be necessary as the development of myelo-erythroid progenitors into megakaryocytes is not inhibited in the thymus, but may instead be enhanced by Notch signals in the thymic environment 108 . Regulated expression of CCR7 and CCR9 serves to prevent bona fide long-term HSCs from migrating to the thymus, thereby ensuring that only those cells that have committed to differentiation (that is, lost self-renewal potential) are candidates for migration. The consequences of thymic settling by HSCs may be similar to what is observed in Lmo2-transgenic mice, in which self-renewing progenitors populate the thymus, exclude further seeding and predispose to tumorigenesis 109 . It is further possible that the use of CCR7-and CCR9-expressing progenitors in thymopoiesis may allow the importation of multiple progenitor populations with distinct lineage potentials and possibly distinct functions. Each of these issues represents a potential focus for future work.
At several stages of thymocyte development, multiple chemokine receptors are implicated in regulating migration, raising the possibility of functional redundancy. The generation of compound-knockout mice (that is, mice deficient in two or more chemokine receptors), in addition to conditional, stage-specific knockout mice as mentioned above, should help to distinguish whether redundancy exists or, alternatively, whether additional mechanisms for controlling stage-specific migration in the thymus need to be identified. These approaches could be particularly informative in helping to elucidate thymocyte migration patterns that are currently poorly understood, such as those controlling the bidirectional movement of thymocytes in the cortex. Further investigation into potential crosstalk between chemokine receptor signalling and pre-TCR or TCR (or cytokine receptor) signalling should provide clearer insight into the important linkage between thymocyte development and migration.
A still largely unexplored area of investigation concerns the molecules that regulate the migration of non-T lineage cells to the thymus. These transient cell populations, which include macrophages and DCs, are crucial for thymocyte selection. Like T cell progenitors, these cells are derived from bone marrow precursors that home to and enter the thymus before undergoing a programme of proliferation and differentiation. In this regard, recent data suggest that thymic recruitment of bone marrow-derived DCs is regulated by chemokines and chemokine receptors that are distinct from those used by thymocytes. For example, thymic DCs express XC-chemokine receptor 1 (XCR1), and its ligand, XC-chemokine ligand 1 (XCL1), is expressed by medullary TECs 110 . Despite these gaps in our current knowledge, much has already been learned about migration during T cell development. These discoveries are likely to result in significant therapeutic applications. Bone marrow transplantation is a relatively common procedure, and cells of the T cell lineage are the slowest to recover following irradiation and bone marrow transplantation, a delay that can be life-threatening 111 . Improvements in our understanding of the molecular basis of thymic homing may allow acceleration of T cell reconstitution following bone marrow ablative therapy for haematological cancers and genetic disorders.
